• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医药治疗慢传输型便秘的研究进展。

Research progress in the treatment of slow transit constipation by traditional Chinese medicine.

机构信息

College of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China; Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.

Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, PR China.

出版信息

J Ethnopharmacol. 2022 May 23;290:115075. doi: 10.1016/j.jep.2022.115075. Epub 2022 Feb 5.

DOI:10.1016/j.jep.2022.115075
PMID:35134487
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Slow transit constipation (STC) is a common gastrointestinal disorder seriously impacting patients' quality of life. At present, although conventional chemical drugs effectively control STC symptoms in the short term, the long-term effects are poor, and the side effects are significant. In this regard, traditional Chinese medicine (TCM) offers an opportunity for STC treatment. Many pharmacological and clinical studies have confirmed this efficacy of TCM with multiple targets and mechanisms.

AIM OF THE STUDY

This review attempted to summarize the characteristics of TCM (compound prescriptions, single Chinese herbs, and active ingredients) for STC treatment and discussed their efficacy based on analyzing the pathogenesis of STC.

MATERIALS AND METHODS

The information was acquired from different databases, including PubMed, Web of Science, China National Knowledge Infrastructure, and Wanfang databases. We then focused on the recent research progress in STC treatment by TCM. Finally, the future challenges and trends are proposed.

RESULTS

TCM has good clinical efficacy in the treatment of STC with multi-mechanisms. Based on the theory of syndrome differentiation, five kinds of dialectical treatment for STC by compound TCM prescriptions were introduced, namely: Nourishing Yin and moistening the intestines; Promoting blood circulation and removing blood stasis; Warming Yang and benefiting Qi; Soothing the liver and regulating Qi; and Benefiting Qi and strengthening the spleen. In addition, six single Chinese herbs and eight active ingredients also show good efficacy in STC treatment.

CONCLUSIONS

TCM, especially compound prescriptions, has bright prospects in treating STC attributed to its various holistic effects.

摘要

民族药理学相关性

慢传输型便秘(STC)是一种常见的胃肠道疾病,严重影响患者的生活质量。目前,虽然常规化学药物能在短期内有效控制 STC 症状,但长期效果不佳,且副作用明显。在这方面,中药(TCM)为 STC 治疗提供了机会。许多药理学和临床研究证实了 TCM 具有多靶点和多机制的疗效。

研究目的

本综述试图总结 TCM(复方方剂、单味中药和活性成分)治疗 STC 的特点,并通过分析 STC 的发病机制来讨论其疗效。

材料和方法

从不同的数据库(包括 PubMed、Web of Science、中国国家知识基础设施和万方数据库)获取信息。然后,我们专注于 TCM 治疗 STC 的最新研究进展。最后,提出了未来的挑战和趋势。

结果

TCM 以多机制治疗 STC 具有良好的临床疗效。基于辨证论治理论,介绍了复方 TCM 方剂治疗 STC 的五种辨证治疗方法,即滋阴润肠、活血化瘀、温阳益气、疏肝理气、益气健脾。此外,六种单味中药和八种活性成分在治疗 STC 方面也显示出良好的疗效。

结论

TCM,特别是复方方剂,在治疗 STC 方面具有广阔的前景,因为它具有多种整体作用。

相似文献

1
Research progress in the treatment of slow transit constipation by traditional Chinese medicine.中医药治疗慢传输型便秘的研究进展。
J Ethnopharmacol. 2022 May 23;290:115075. doi: 10.1016/j.jep.2022.115075. Epub 2022 Feb 5.
2
Treatment of neuropathic pain by traditional Chinese medicine: An updated review on their effect and putative mechanisms of action.中医药治疗神经性疼痛:作用及作用机制的更新评价。
Phytother Res. 2024 Jun;38(6):2962-2992. doi: 10.1002/ptr.8180. Epub 2024 Apr 10.
3
The clinical experiences of Dr. CAI Gan in treating chronic constipation.蔡淦教授治疗慢性便秘的临床经验。
J Tradit Chin Med. 2009 Sep;29(3):205-8. doi: 10.1016/s0254-6272(09)60066-2.
4
The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine.从中医角度看帕金森病的发病机制及治疗机理。
Phytomedicine. 2022 Jun;100:154044. doi: 10.1016/j.phymed.2022.154044. Epub 2022 Mar 15.
5
Review on the potential roles of traditional Chinese medicines in the prevention, treatment, and postoperative recovery of age-related cataract.中药在年龄相关性白内障预防、治疗及术后恢复中的潜在作用综述
J Ethnopharmacol. 2024 Apr 24;324:117786. doi: 10.1016/j.jep.2024.117786. Epub 2024 Jan 20.
6
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.中药复方抗肝纤维化治疗的研究进展。
J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28.
7
Traditional Chinese medicine treats ulcerative colitis by regulating gut microbiota, signaling pathway and cytokine: Future novel method option for pharmacotherapy.中医通过调节肠道微生物群、信号通路和细胞因子来治疗溃疡性结肠炎:药物治疗的未来新方法选择。
Heliyon. 2024 Mar 6;10(6):e27530. doi: 10.1016/j.heliyon.2024.e27530. eCollection 2024 Mar 30.
8
An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms.一种优化的治疗肝纤维化的草药组合:关键基因、生物活性成分和分子机制。
J Ethnopharmacol. 2022 Oct 28;297:115567. doi: 10.1016/j.jep.2022.115567. Epub 2022 Jul 20.
9
[Regularity analysis on clinical treatment in primary liver cancer by traditional Chinese medicine].[中医治疗原发性肝癌的临床规律分析]
Zhongguo Zhong Yao Za Zhi. 2012 May;37(9):1327-31.
10
Syndrome Differentiation and Treatment Regularity in Traditional Chinese Medicine for Type 2 Diabetes: A Text Mining Analysis.中医治疗 2 型糖尿病的辨证施治规律:文本挖掘分析。
Front Endocrinol (Lausanne). 2021 Dec 23;12:728032. doi: 10.3389/fendo.2021.728032. eCollection 2021.

引用本文的文献

1
Unveiling Xuanshen decoction: A novel approach to combat slow transit constipation.揭示玄参汤:一种治疗慢传输型便秘的新方法。
World J Gastroenterol. 2025 Aug 14;31(30):109187. doi: 10.3748/wjg.v31.i30.109187.
2
Relieving effect of an Maren-Zhizhu emulsion on loperamide hydrochloride-induced constipation in mice and its effects on the gut microbiota.马仁枳术乳剂对盐酸洛哌丁胺诱导的小鼠便秘的缓解作用及其对肠道微生物群的影响
Front Microbiol. 2025 Aug 13;16:1641367. doi: 10.3389/fmicb.2025.1641367. eCollection 2025.
3
Study of NOX4/ROS/NF-κB signaling pathway in anti-ischemia-reperfusion injury effect and mechanism of STQJD.
通窍救心滴丸抗缺血再灌注损伤作用及机制中NOX4/ROS/NF-κB信号通路的研究
Am J Transl Res. 2025 Jul 15;17(7):4894-4911. doi: 10.62347/MLZI7617. eCollection 2025.
4
Laxative effect of Zengye granule by modulating the SCF/c-Kit pathway and gut microbiota in constipated mice.增液颗粒通过调节便秘小鼠的SCF/c-Kit通路和肠道微生物群发挥通便作用。
Front Vet Sci. 2025 Jun 18;12:1628570. doi: 10.3389/fvets.2025.1628570. eCollection 2025.
5
Naringenin attenuates slow-transit constipation by regulating the AMPK/mTOR/ULK1 signalling pathway: and studies.柚皮素通过调节AMPK/mTOR/ULK1信号通路减轻慢传输型便秘: 及 研究。 (你提供的原文中“and”前后内容似乎不完整,可能影响准确理解。)
Front Pharmacol. 2025 Jun 17;16:1550458. doi: 10.3389/fphar.2025.1550458. eCollection 2025.
6
Huangqi decoction ameliorated intestinal barrier dysfunction regulating NF-κB signaling pathway in slow transit constipation model mice.黄芪汤通过调节慢传输型便秘模型小鼠的NF-κB信号通路改善肠道屏障功能障碍。
World J Gastrointest Surg. 2025 May 27;17(5):106000. doi: 10.4240/wjgs.v17.i5.106000.
7
Gut-brain axis mediated by intestinal content microbiota was associated with Zhishi Daozhi decoction on constipation.由肠道内容物微生物群介导的肠-脑轴与枳实导滞汤治疗便秘有关。
Front Cell Infect Microbiol. 2025 Feb 3;15:1539277. doi: 10.3389/fcimb.2025.1539277. eCollection 2025.
8
Use of 16s RNA and metabolomics to investigate the therapeutic effect of Zhuyang Tongbian Decoction on mice with functional constipation.运用16s RNA和代谢组学研究助阳通便汤对功能性便秘小鼠的治疗作用。
Am J Transl Res. 2025 Jan 15;17(1):87-103. doi: 10.62347/MBJY3014. eCollection 2025.
9
Effectiveness of abdominal electroacupuncture therapy for poststroke constipation: a meta-analysis.腹部电针疗法治疗脑卒中后便秘的有效性:一项Meta分析
Front Neurol. 2024 Nov 22;15:1480681. doi: 10.3389/fneur.2024.1480681. eCollection 2024.
10
Integrated serum pharmacochemistry, 16S rDNA sequencing, and metabolomics to reveal the material basis and mechanism of Shouhui Tongbian capsule against diphenoxylate-induced slow transit constipation in rats.采用血清药物化学、16S rDNA测序和代谢组学技术揭示守回通便胶囊抗地芬诺酯致大鼠慢传输型便秘的物质基础及作用机制。
Chin Med. 2024 Oct 11;19(1):142. doi: 10.1186/s13020-024-01015-8.